NEU 3.15% $21.27 neuren pharmaceuticals limited

Ann: Neuren completes Phelan-McDermid syndrome Phase 2 trial, page-50

  1. 896 Posts.
    lightbulb Created with Sketch. 331
    Re enrolment in other trials - maybe some savvy people are waiting for the PMS results - all 4 phase 1 trials are testing "the safety, tolerability, and efficacy of NNZ-2591".

    I know if I knew this and that there were results of a parallel trial due within weeks/days - I might just wait and enrol my child if/when the first phase 1 trial is positive or at least shows very little signs of unsafety, intolerability or non efficacy.

    And imho - it will be positive and that will just be a blockbuster event for Neuren and all of these people, opening many doors for the way ahead.
    Last edited by giarc63: 30/11/23
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$21.27
Change
0.650(3.15%)
Mkt cap ! $2.718B
Open High Low Value Volume
$20.84 $21.56 $20.76 $7.760M 364.5K

Buyers (Bids)

No. Vol. Price($)
2 1378 $21.24
 

Sellers (Offers)

Price($) Vol. No.
$21.29 218 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.